Total raised
—
Stage
Pre-Funding
Founded
2013
Headcount
1-10
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Adastroderm is focused on dermatology, developing a medical device targeted to improve early stage diagnosis of malignant melanoma. The company develops a healthy aging Pharma drug in a P2 clinical stage, as well.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Adastroderm's primary focus in the medical field?
- Adastroderm is focused on dermatology, developing a medical device for early stage diagnosis of malignant melanoma.
- What other product is Adastroderm developing besides its melanoma detection device?
- Adastroderm is also developing a healthy aging Pharma drug, which is currently in a P2 clinical stage.
- When was Adastroderm founded?
- Adastroderm was founded in January 2013.
- What is the current status of Adastroderm?
- Adastroderm is currently inactive, as of April 2016.
- Where is Adastroderm headquartered?
- Adastroderm is headquartered in Tel Aviv-Yafo, Israel.
- What is Adastroderm's current funding stage?
- Adastroderm is in the Pre-Funding stage.
- How many employees does Adastroderm have?
- Adastroderm has between 1-10 employees.
- Who is a known founder of Adastroderm?
- Avi Dascalu is a founder of Adastroderm.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Tags
early-detectioncancermedical-devicesoncologydrug-developmentdermatology